Kayla Antosz

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Prisma Health(Current)

University of South Carolina

High Point University

Beth Israel Deaconess Medical Center

University of Mississippi Medical Center

Kayla Antosz is an author at Prisma Health specializing in pseudomonas aeruginosa infection treatment, pharmacotherapy, and outpatient parenteral antimicrobial therapy.

ORCID

Publications per year

2021–2025

Publications

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf et al. · Open Forum Infectious Diseases · 2021 · 32 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care

Kayla Antosz, Majdi N. Al‐Hasan, Kevin Lu et al. · Pharmacy · 2021 · 16 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study

Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali et al. · Open Forum Infectious Diseases · 2025 · 11 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series

Erin Warren, R. Jake Crocker, Benjamin Tabor et al. · JAC-Antimicrobial Resistance · 2022 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–4 of 4